You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

itacitinib

Showing 1 - 25 of 39
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bronchiolitis Obliterans Trial in Houston (Itacitinib, Itacitinib Adipate)

Recruiting
  • Bronchiolitis Obliterans
  • Itacitinib
  • Itacitinib Adipate
  • Houston, Texas
    M D Anderson Cancer Center
Jan 24, 2023

Leukemia, Acute, MDS, Myelomonocytic Leukemia, Chronic Trial (Itacitinib)

Not yet recruiting
  • Leukemia, Acute
  • +7 more
  • Itacitinib
  • (no location specified)
Apr 10, 2023

Diffuse Large B Cell Lymphoma Trial in Tampa (Itacitinib, Chimeric antigen receptor (CAR) T-cell therapy)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Itacitinib
  • Chimeric antigen receptor (CAR) T-cell therapy
  • Tampa, Florida
    Moffitt Cancer Center
Mar 6, 2023

Chronic Graft-versus-host-disease Trial in Salt Lake City (Itacitinib, Extracorporeal Photopheresis (ECP))

Active, not recruiting
  • Chronic Graft-versus-host-disease
  • Itacitinib
  • Extracorporeal Photopheresis (ECP)
  • Salt Lake City, Utah
    Huntsman Cancer Institute at University of Utah
Jan 30, 2023

Classical Hodgkin Lymphoma Trial in Philadelphia (Itacitinib, Everolimus)

Active, not recruiting
  • Classical Hodgkin Lymphoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Nov 28, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Nashville (Itacitinib, Corticosteroid, Endoscopic

Not yet recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Itacitinib
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Dec 20, 2022

Adults Patients Having Non Severe HLH Trial in Bobigny (Itacitinib)

Recruiting
  • Adults Patients Having Non Severe HLH
  • Itacitinib
  • Bobigny, France
    Hôpital Avicenne
Aug 22, 2022

STAT1 Gain-of-Function Disease Trial (Itacitinib)

Available
  • STAT1 Gain-of-Function Disease
  • Itacitinib
  • (no location specified)
Sep 30, 2022

Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle

Recruiting
  • Metastatic Leiomyosarcoma
  • +17 more
  • Itacitinib
  • Laboratory Biomarker Analysis
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 13, 2022

Bronchiolitis Obliterans Syndrome Trial in Belgium, Canada, United States (Itacitinib)

Active, not recruiting
  • Bronchiolitis Obliterans Syndrome
  • Itacitinib
  • Los Angeles, California
  • +8 more
Oct 14, 2022

Cytokine Release Syndrome Trial in United States (Itacitinib, Immune effector cell therapy, Placebo)

Recruiting
  • Cytokine Release Syndrome
  • Itacitinib
  • +3 more
  • Miami, Florida
  • +9 more
Oct 25, 2022

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, MDS Trial in Saint Louis (procedure, drug, other)

Recruiting
  • Acute Myelogenous Leukemia
  • +4 more
  • Stem cell transplantation
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 23, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Duarte (drug, procedure, other)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Myelofibrosis Trial in Canada, United States (itacitinib)

Recruiting
  • Myelofibrosis
  • itacitinib
  • Aurora, Colorado
  • +4 more
Mar 8, 2022

Lymphoma Trial in United States (itacitinib, ibrutinib)

Completed
  • Lymphoma
  • Scottsdale, Arizona
  • +20 more
Nov 14, 2022

Hematologic and Lymphocytic Disorder Trial in Houston (Allogeneic Hematopoietic Stem Cell Transplantation, Busulfan,

Recruiting
  • Hematologic and Lymphocytic Disorder
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 1, 2022

Chronic Graft-versus-host-disease Trial in United States (Itacitinib)

Recruiting
  • Chronic Graft-versus-host-disease
  • Itacitinib
  • Denver, Colorado
  • +4 more
Jan 24, 2022

Systemic Sclerosis Trial in France (Itacitinib, Placebo)

Not yet recruiting
  • Systemic Sclerosis
  • Itacitinib
  • Placebo
  • Amiens, France
  • +33 more
Jun 7, 2022

Hematologic Malignancies Trial in Worldwide (Itacitinib, Calcineurin inhibitor)

Terminated
  • Hematologic Malignancies
  • Itacitinib
  • Calcineurin inhibitor
  • Aurora, Colorado
  • +16 more
Apr 29, 2022

Myelofibrosis, Polycythemia Vera, Thrombocythemia Trial in Worldwide (itacitinib)

Active, not recruiting
  • Myelofibrosis
  • +2 more
  • itacitinib
  • New Orleans, Louisiana
  • +20 more
Aug 25, 2022

MDS/MPN Trial in Nashville (ASTX727, Itacitinib)

Recruiting
  • MDS/MPN
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Jun 20, 2022

MPN (Myeloproliferative Tumors) Trial in Australia, Canada, United States (itacitinib)

Completed
  • MPN (Myeloproliferative Neoplasms)
  • itacitinib
  • Birmingham, Alabama
  • +21 more
Aug 25, 2021

Colorectal Cancer (CRC), Endometrial Cancer, Melanoma Trial in United States (Pembrolizumab, itacitinib, INCB050465)

Completed
  • Colorectal Cancer (CRC)
  • +10 more
  • San Francisco, California
  • +16 more
Mar 30, 2022

Lung Cancer Trial in Worldwide (Itacitinib, Osimertinib)

Active, not recruiting
  • Lung Cancer
  • La Jolla, California
  • +30 more
Mar 8, 2022

Allogeneic Stem Cell Transplant Recipient, Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid Cell Tumor Trial in

Withdrawn
  • Allogeneic Stem Cell Transplant Recipient
  • +2 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 27, 2020